Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Dulaglutide (brand name Trulicity) is a long-acting GLP-1 receptor agonist approved by the FDA in 2014 for adults with type 2 diabetes, and later for cardiovascular risk reduction in people with established or high cardiovascular risk
And like the rest of this drug class, it will raise the usual questions about long-term use, cost, access and what happens when treatment stops
Lotosky, J., Jean, X., Altankhuyag, A., Khan, S., Bernotas, A., Sharafshah, A., Blum, K., Posner, A., & Thanos, P
Lawsuits against Eli Lilly and Novo Nordisk are being consolidated into multidistrict litigation (MDL) in the U.S
Wu PI, Diaz R, Borg-Stein J
US$ 25.53
US$ 20.94
US$ 22.02
